These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 6197797

  • 1. [Sublingual buprenorphine in the treatment of pain caused by cancer. Transition to buprenorphine from other opiates].
    Enig B.
    Ugeskr Laeger; 1983 Oct 17; 145(42):3236-40. PubMed ID: 6197797
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Switching from transdermal drugs: an observational "N of 1" study of fentanyl and buprenorphine.
    Mercadante S, Porzio G, Fulfaro F, Aielli F, Verna L, Ficorella C, Casuccio A, Riina S, Intravaia G, Mangione S.
    J Pain Symptom Manage; 2007 Nov 17; 34(5):532-8. PubMed ID: 17629666
    [Abstract] [Full Text] [Related]

  • 8. [Effect of a long-acting analgesic, buprenorphine on cancer pain--a single-blind crossover comparison with pentazocine].
    Taguchi T.
    Gan To Kagaku Ryoho; 1982 Feb 17; 9(2):250-7. PubMed ID: 7184401
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Prevention of postoperative pain with buprenorphine, morphine or pethidine].
    Isaksen B, Mikkelsen H, Bryne H.
    Tidsskr Nor Laegeforen; 1982 Nov 10; 102(31):1647-8. PubMed ID: 6762690
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Buprenorphine: new tricks with an old molecule for pain management.
    Heit HA, Gourlay DL.
    Clin J Pain; 2008 Feb 10; 24(2):93-7. PubMed ID: 18209513
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intravenous naloxone plus transdermal buprenorphine in cancer pain associated with intractable cholestatic pruritus.
    Marinangeli F, Guetti C, Angeletti C, Bonetti C, Paladini A, Piroli A, Varrassi G.
    J Pain Symptom Manage; 2009 Oct 10; 38(4):e5-8. PubMed ID: 19699606
    [No Abstract] [Full Text] [Related]

  • 19. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival.
    Ripamonti C, Brunelli C.
    J Clin Oncol; 2003 Jul 15; 21(14):2801-2; author reply 2802-3. PubMed ID: 12860959
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.